RORγ is constitutively activated by endogenous cholesterol-like ligands in the cell, and we used our small-molecule compound library to discover novel RORγ inhibitors that could be suitable for the treatment of autoimmune diseases. This evidence concerns the gene RORC and autoimmune disease.